Biofabrication of poly(l-lactide-co-ε-caprolactone)/silk fibroin scaffold for the application as superb anti-calcification tissue engineered prosthetic valve
Creators
- 1. Tianjin Key Laboratory of Biomaterial Research, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192 (China)
- 2. Tianjin Enterprise Key Laboratory for Application Research of Hyaluronic Acid, Tianjin 300385 (China)
- 3. Key Laboratory of Bioactive Materials of Ministry of Education, State Key Laboratory of Medicinal Chemical Biology, College of Life Science, Nankai University, Tianjin 300071 (China)
Description
Highlights: • A PLCL/SF electrospun scaffolds was fabricated and its feasibility as TEHV materials has been verified. • The PLCL/SF electrospun scaffolds exhibited excellent mechanical and anti-calcification properties. • Compared with clinically used porcine pericardium, the calcification level of PLCL/SF electrospun scaffolds was much lower. • All these above results indicated great potential of PLCL/SF electrospun scaffolds used in the field of TEHV materials. In this study, electrospun scaffolds were fabricated by blending poly(l-lactide-co-ε-caprolactone) (PLCL) and silk fibroin (SF) with different ratios, and further the feasibility of electrospun PLCL/SF scaffolds were evaluated for application of tissue engineered heart valve (TEHV). Scanning electron microscopy (SEM) results showed that the surface of PLCL/SF electrospun scaffolds was smooth and uniform while the mechanical properties were appropriate as valve prosthesis. In vitro cytocompatibility evaluation results demonstrated that all of the PLCL/SF electrospun scaffolds were cytocompatible and valvular interstitial cells (VICs) cultured on PLCL/SF scaffolds of 80/20 & 70/30 ratios exhibited the best cytocompatibility. The in vitro osteogenic differentiation of VICs including alkaline phosphatase (ALP) activity and quantitative polymerase chain reaction (qPCR) assays indicated that PLCL/SF scaffolds of 80/20 & 90/10 ratios behaved better anti-calcification ability. In the in vivo calcification evaluation model of rat subdermal implantation, PLCL/SF scaffolds of 80/20 & 90/10 ratios presented better anti-calcification ability, which was consistent with the in vitro results. Moreover, PLCL/SF scaffolds of 80/20 & 70/30 ratios showed significantly enhanced cell infiltration and M2 macrophage with higher CD206+/CD68+ ratio. Collectively, our data demonstrated that electrospun scaffolds with the PLCL/SF ratio of 80/20 hold great potential as TEHV materials.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.msec.2021.111872Additional details
Identifiers
- DOI
- 10.1016/j.msec.2021.111872;
- PII
- S0928493121000102;
Publishing Information
- Journal Title
- Materials Science and Engineering. C, Biomimetic Materials, Sensors and Systems
- Journal Volume
- 121
- Journal Page Range
- vp.
- ISSN
- 0928-4931
INIS
- Country of Publication
- Netherlands
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 54045689
- Subject category
- S36: MATERIALS SCIENCE; S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- ALKALINE PHOSPHATASE; IN VITRO; IN VIVO; MATERIALS; MECHANICAL PROPERTIES; PERICARDIUM; POLYMERASE CHAIN REACTION; POLYMERASES; RATS; SCANNING ELECTRON MICROSCOPY; SURFACES; VALVES
- Descriptors DEC
- ANIMALS; BODY; CARDIOVASCULAR SYSTEM; CONTROL EQUIPMENT; ELECTRON MICROSCOPY; ENZYMES; EQUIPMENT; ESTERASES; FLOW REGULATORS; GENE AMPLIFICATION; HEART; HYDROLASES; MAMMALS; MEMBRANES; MICROSCOPY; NUCLEOTIDYLTRANSFERASES; ORGANIC COMPOUNDS; ORGANS; PHOSPHATASES; PHOSPHORUS-GROUP TRANSFERASES; PROTEINS; RODENTS; SEROUS MEMBRANES; TRANSFERASES; VERTEBRATES
Optional Information
- Copyright
- Copyright (c) 2021 Elsevier B.V. All rights reserved.